Staff
Oncology
Dr. Omer N. Koc, MD
|
|
Give Review
Omer N. Koc, MD is an expert in the field of Oncology. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Doctor Omer N. Koc, MD has written publications. He has 24 publications published with PubMed. The lastest paper is: 'Mucormycosis of petrous bone in an allogeneic stem cell transplant recipient.' He is registered with Medicare.
Publications
- A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell Lymphoma.
- SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction.
- Peritransplant use of ultraviolet-B irradiation (UV-B) therapy is detrimental to allogeneic stem cell transplantation outcome.
- A perspective for the selection of surgical approaches in patients With upper thoracic and cervicothoracic junction instabilities.
- Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in Hematologic malignancy patients.
- High-dose carmustine, etoposide, and cisplatin for autologous stem cell transplantation with or without involved-field radiation for relapsed/refractory Lymphoma: an e...
- A phase I and pharmacodynamic study of fludarabine, carboplatin, and topotecan in patients with relapsed, refractory, or high-risk Acute leukemia.
- Akt helps stem cells heal the heart.
- Folliculotropic mycosis fungoides with central Nervous system involvement: demonstration of tumor clonality in intrafollicular T cells using laser capture microdissect...
- Expansion of LTC-ICs and maintenance of p21 and BCL-2 expression in cord blood CD34(+)/CD38(-) early progenitors cultured over human MSCs as a feeder layer.
- Familial severe congenital neutropenia Associated with infantile osteoporosis: a new entity.
- Mirizzi''s Syndrome must be ruled out in the differential diagnosis of any patients with obstructive jaundice.
- Detection of platinum-DNA adDucts in cord blood lymphocytes following in utero platinum exposure.
- Current progress in the gene therapy of Cancer.
- Pre-mobilization therapy blood CD34+ cell count predicts the likelihood of successful hematopoietic stem cell mobilization.
- Retroviral transDuction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells.
- Mucormycosis of petrous bone in an allogeneic stem cell transplant recipient.
- Hematopoietic enGraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.
- The surface adhesion molecule CXCR4 stimulates mesenchymal stem cell migration to stromal cell-derived factor-1 in vitro but does not decrease apoptosis under serum de...
- N-benzoylstaurosporine (PKC412) inhibits Akt kinase inducing apoptosis in multiple myeloma cells.
- Kinetics of Myeloid and lymphocyte recovery and infectious complications after unrelated umbilical cord blood versus HLA-matched unrelated donor allogeneic transplanta...
- Hematopoietic recovery after unrelated umbilical cord-blood allogeneic transplantation in adults treated With in vivo stem cell factor (R-MetHuSCF) and filgrastim admi...
- Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin Lymphoma.
Schools
Istanbul Universitesi Cerrahpasa Tip Fakultesi
Cleveland Clin Found
University Hosps Cleveland
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Case Western Reserve University - University Hospitals -
Cleveland Clinic Foundation -
Istanbul University Faculty of Medicine
Hospital
-
Cleveland Clinic
Drug Facts
| NPI NUMBER | 1588629059 | |
| NPPES Provider LastName | KOC | |
| NPPES Provider FirstName | OMER | |
| NPPES Provider ZIPCode | 441950001 | |
| NPPES Provider State | OH | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 1565.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 61.0 | |
| Percent Opioid Claims | 3.9 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1588629059 |
| Last Name Of The Provider | KOC |
| First Name Of The Provider | OMER |
| View All |
Similar Doctors
|
Dr. Lois J. Teston, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vinit K. Makkar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary A. Schnur, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Prateek Mendiratta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy E. Cocco, MD |
|
|
Dr. Neha Mitra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samir N. Abraksia, MD
This Doctor is OpenDoctor Recommended.
|